BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ferolla SM, Armiliato GNA, Couto CA, Ferrari TCA. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol 2015; 7(3): 559-565 [PMID: 25848479 DOI: 10.4254/wjh.v7.i3.559]
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/559.htm
Number Citing Articles
1
Xuyun He, Guang Ji, Wei Jia, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsInternational Journal of Molecular Sciences 2016; 17(3): 300 doi: 10.3390/ijms17030300
2
Y.-H. Ho, Y.-T. Huang, Y.-C. Lu, S.-Y. Lee, M.-F. Tsai, S.-P. Hung, Ting-Yuan Hsu. Effects of gender and age on immune responses of human peripheral blood mononuclear cells to probiotics: A large scale pilot studyThe journal of nutrition, health & aging 2017; 21(5): 521 doi: 10.1007/s12603-016-0818-7
3
Makoto Usami, Makoto Miyoshi, Hayato Yamashita. Gut microbiota and host metabolism in liver cirrhosisWorld Journal of Gastroenterology 2015; 21(41): 11597-11608 doi: 10.3748/wjg.v21.i41.11597
4
Alessandro Federico, Marcello Dallio, Justyna Godos, Carmela Loguercio, Federico Salomone. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidenceTranslational Research 2016; 167(1): 116 doi: 10.1016/j.trsl.2015.08.002
5
Guido Carpino, Maria Del Ben, Daniele Pastori, Roberto Carnevale, Francesco Baratta, Diletta Overi, Heather Francis, Vincenzo Cardinale, Paolo Onori, Samira Safarikia, Vittoria Cammisotto, Domenico Alvaro, Gianluca Svegliati‐Baroni, Francesco Angelico, Eugenio Gaudio, Francesco Violi. Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLDHepatology 2020; 72(2): 470 doi: 10.1002/hep.31056
6
Mustafa Tahsin Yilmaz, Osman Taylan, Canan Yagmur Karakas, Enes Dertli. An alternative way to encapsulate probiotics within electrospun alginate nanofibers as monitored under simulated gastrointestinal conditions and in kefirCarbohydrate Polymers 2020; 244: 116447 doi: 10.1016/j.carbpol.2020.116447
7
Yan Yan, Chunyan Liu, Shimin Zhao, Xinxu Wang, Jinling Wang, Heping Zhang, Yuzhen Wang, Guofen Zhao. Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver diseaseAMB Express 2020; 10(1) doi: 10.1186/s13568-020-01038-y
8
Amin Salehi-Abargouei, Reza Ghiasvand, Mitra Hariri. Prebiotics, Prosynbiotics and Synbiotics: Can They Reduce Plasma Oxidative Stress Parameters? A Systematic ReviewProbiotics and Antimicrobial Proteins 2017; 9(1): 1 doi: 10.1007/s12602-016-9248-4
9
Mariana Machado, Helena Cortez-Pinto. Diet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetInternational Journal of Molecular Sciences 2016; 17(4): 481 doi: 10.3390/ijms17040481
10
Yupei Zhang, Kairui Tang, Yuanjun Deng, Runsen Chen, Shu Liang, Huijun Xie, Yifang He, Yanning Chen, Qinhe Yang. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD ratsBiomedicine & Pharmacotherapy 2018; 102: 1025 doi: 10.1016/j.biopha.2018.03.158
11
M.-Y. Park, S.J. Kim, E.K. Ko, S.-H. Ahn, H. Seo, M.-K. Sung. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob miceJournal of Applied Microbiology 2016; 121(3): 800 doi: 10.1111/jam.13158
12
Mingfei Yao, Jiong Wu, Bo Li, Hang Xiao, David Julian McClements, Lanjuan Li. Microencapsulation of Lactobacillus salivarious Li01 for enhanced storage viability and targeted delivery to gut microbiotaFood Hydrocolloids 2017; 72: 228 doi: 10.1016/j.foodhyd.2017.05.033
13
Niama Ezzaidi, Xiang Zhang, Olabisi Oluwabukola Coker, Jun Yu. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancerCancer Letters 2019; 459: 186 doi: 10.1016/j.canlet.2019.114425
14
Bashar Aqel, John K. DiBaise. Role of the Gut Microbiome in Nonalcoholic Fatty Liver DiseaseNutrition in Clinical Practice 2015; 30(6): 780 doi: 10.1177/0884533615605811
15
Juanjuan Zhu, Mingyu Zhou, Xueke Zhao, Mao Mu, Mingliang Cheng. Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver diseaseviaIL-22-mediated JAK1/STAT3/BAX signalingFood & Function 2018; 9(12): 6298 doi: 10.1039/C8FO01227J
16
Haiming Hu, Aizhen Lin, Mingwang Kong, Xiaowei Yao, Mingzhu Yin, Hui Xia, Jun Ma, Hongtao Liu. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectivesJournal of Gastroenterology 2020; 55(2): 142 doi: 10.1007/s00535-019-01649-8
17
Yi‐Ming Chen, Chen‐Chung Liao, Yen‐Chun Huang, Ming‐Yi Chen, Chi‐Chang Huang, Wen‐Chyuan Chen, Yen‐Shuo Chiu. Proteome and microbiota analysis highlight Lactobacillus plantarum TWK10 supplementation improves energy metabolism and exercise performance in mice Food Science & Nutrition 2020; 8(7): 3525 doi: 10.1002/fsn3.1635
18
Fatemeh Famouri, Zainab Shariat, Mahin Hashemipour, Mojtaba Keikha, Roya Kelishadi. Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and AdolescentsJournal of Pediatric Gastroenterology & Nutrition 2017; 64(3): 413 doi: 10.1097/MPG.0000000000001422
19
Leila Javadi, Mostafa Ghavami, Manouchehr Khoshbaten, Abdolrasoul Safaiyan, Abolfazl Barzegari, Bahram Pourghassem Gargari. The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical TrialIranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.46017
20
Huikuan Chu, Brandon Williams, Bernd Schnabl. Gut microbiota, fatty liver disease, and hepatocellular carcinomaLiver Research 2018; 2(1): 43 doi: 10.1016/j.livres.2017.11.005
21
Diletta Overi, Guido Carpino, Antonio Franchitto, Paolo Onori, Eugenio Gaudio. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic SteatohepatitisCells 2020; 9(3): 590 doi: 10.3390/cells9030590
22
Childhood Obesity2016; : 293 doi: 10.1201/9781315370958-28
23
Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus. The role of the gut microbiota in NAFLDNature Reviews Gastroenterology & Hepatology 2016; 13(7): 412 doi: 10.1038/nrgastro.2016.85
24
Richard LJ Day, Ashton J Harper, Rachel M Woods, Owen G Davies, Liam M Heaney. Probiotics: current landscape and future horizonsFuture Science OA 2019; 5(4): FSO391 doi: 10.4155/fsoa-2019-0004
25
Zahra Safari, Philippe Gérard. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)Cellular and Molecular Life Sciences 2019; 76(8): 1541 doi: 10.1007/s00018-019-03011-w
26
Giorgia Spaggiari, Giulia Brigante, Sara De Vincentis, Umberto Cattini, Laura Roli, Maria Cristina De Santis, Enrica Baraldi, Simonetta Tagliavini, Manuela Varani, Tommaso Trenti, Vincenzo Rochira, Manuela Simoni, Daniele Santi. Probiotics Ingestion Does Not Directly Affect Thyroid Hormonal Parameters in Hypothyroid Patients on Levothyroxine TreatmentFrontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00316
27
Ruiting Han, Junli Ma, Houkai Li. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiotaFrontiers of Medicine 2018; 12(6): 645 doi: 10.1007/s11684-018-0645-9